ID
17938
Beschrijving
A Phase 2 Study of Tarceva for Untreated, Good Prognosis Patients With Advanced Non-Small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00585533
Link
https://clinicaltrials.gov/show/NCT00585533
Trefwoorden
Versies (1)
- 11-10-16 11-10-16 -
Geüploaded op
11 oktober 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Lung Cancer NCT00585533
Eligibility Lung Cancer NCT00585533
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
Pregnancy | Breast Feeding
Datatype
boolean
Alias
- UMLS CUI [1]
- C0032961
- UMLS CUI [2]
- C0006147
Beschrijving
Metastatic malignant neoplasm to brain
Datatype
boolean
Alias
- UMLS CUI [1]
- C0220650
Beschrijving
Prior Chemotherapy Systemic disease
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C1514457
- UMLS CUI [1,2]
- C0442893
Beschrijving
organ dysfunction Impending | Chemotherapy Patient need for
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0349410
- UMLS CUI [1,2]
- C0332190
- UMLS CUI [2,1]
- C0392920
- UMLS CUI [2,2]
- C0686904
Similar models
Eligibility Lung Cancer NCT00585533
- StudyEvent: Eligibility
C0858307 (UMLS CUI [2])
C3846005 (UMLS CUI [1,2])
C2911577 (UMLS CUI [2,1])
C2826292 (UMLS CUI [2,2])
C0006147 (UMLS CUI [2])
C0442893 (UMLS CUI [1,2])
C0332190 (UMLS CUI [1,2])
C0392920 (UMLS CUI [2,1])
C0686904 (UMLS CUI [2,2])